Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma

2013 ◽  
Vol 420 ◽  
pp. 45-53 ◽  
Author(s):  
Yi-Ting Chen ◽  
Yi-Min Chong ◽  
Chu-Wen Cheng ◽  
Chung-Liang Ho ◽  
Hung-Wen Tsai ◽  
...  

2020 ◽  
Vol 130 (3) ◽  
pp. e213-e214
Author(s):  
MYCAELLE STEPHANNY DAS NEVES BARBOSA SENA ◽  
CLAYTON CLENISSON DE CARVALHO SILVA ◽  
VANESSA DE CARLA BATISTA DOS SANTOS ◽  
LARISSA TINô DE CARVALHO SILVA ◽  
INGRID FERREIRA LEITE ◽  
...  

2021 ◽  
Author(s):  
Bi Lin ◽  
Jun Wu ◽  
Yanxing Wang ◽  
Song Sun ◽  
Ying Yuan ◽  
...  

Early diagnosis is critical and challenging for tongue squamous cell carcinoma (TSCC), which is a kind of tumor with high malignancy, poor prognosis, and a high incidence of invasion and metastasis.


Author(s):  
BRUNA FERNANDES DO CARMO CARVALHO ◽  
VICTOR COSTA ◽  
CESAR AUGUSTO CARDOSO ◽  
ANA LIA ANBINDER ◽  
ESTELA KAMINAGAKURA ◽  
...  

2021 ◽  
Vol 22 (22) ◽  
pp. 12215
Author(s):  
Francisco Javier Manzano-Moreno ◽  
Victor J. Costela-Ruiz ◽  
Enrique García-Recio ◽  
Maria Victoria Olmedo-Gaya ◽  
Concepción Ruiz ◽  
...  

Oral squamous cell carcinoma (OSCC) is the most prevalent oral malignant tumor worldwide. An early diagnosis can have a major positive impact on its prognosis. Human saliva contains cytokines, DNA and RNA molecules, circulating cells, and derivatives of tissues and extracellular vesicles, among other factors that can serve as biomarkers. Hence, the analysis of saliva may provide useful information for the early diagnosis of OSCC for its prognosis. The objective of this review was to determine the potential usefulness of salivary biomarkers (cytokines and microRNA) to diagnose OSCC and improve its prognosis. A combination of salivary miRNA and proteomic data could allow a definitive and early diagnosis to be obtained. However, there remains a need to optimize and standardize the protocols used to quantify miRNAs.


Sign in / Sign up

Export Citation Format

Share Document